Cardiologists and oncologists must work together in an attempt to avoid or prevent adverse cardiovascular effects in patients from certain chemotherapies, especially for those who may be at a higher risk for such effects, according to a new review published online December 10 in the Journal of the National Cancer Institute. With an aging population, it is highly probable that an increasing number of people may have both cancer and cardiovascular disease…

A cutting edge technique that allows scientists to monitor communication between cells could transform the way laboratory medical experiments are conducted. The method is likely to make laboratory studies of cancers and other human diseases, and assessment of new drugs to target them, more accurate.

People who drink may want to know that coffee won’t sober them up, according to new laboratory research. Instead, a cup of coffee may make it harder for people to realize they’re drunk

Pediatric researchers have found that a gene already implicated in the development of type 2 diabetes in adults also raises the risk of being overweight during childhood. The finding sheds light on the genetic origins of diabetes and may present an avenue for developing drugs to counteract the disease, which has been on the upswing in childhood and adolescence

Men of all ages treated for prostate cancer with androgen deprivation therapy, specifically with gonadotropin-releasing hormone agonists (GnRH), have an increased risk of diabetes and cardiovascular disease, according to a new study published online December 7 in the Journal of the National Cancer Institute. Previous studies indicate that older men who take androgen deprivation therapy for prostate cancer are at an increased risk for diabetes and cardiovascular disease, but the relationship between the two among men of all ages is unclear.